Jan Willem Mathijs Hoekstra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jan Willem Mathijs Hoekstra has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Edwin Mattheus Ongkosuwito
Department of Dentistry—Orthodontics and Craniofacial Biology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands
2 shared publications - Jeroen J. J. P. van Den Beucken
Department of Dentistry‐Regenerative Biomaterials Radboud Institute for Medical Innovation Radboud University Medical Center Nijmegen The Netherlands
2 shared publications John A. Jansen
Dentistry – Regenerative Biomaterials (309), Radboudumc Nijmegen The Netherlands
2 shared publications- Arianne de Blaeij
RIVM, Centre for Safety of Substances and Products Bilthoven The Netherlands
1 shared publication - Bart A. J. A. van Oirschot
Department of Dentistry—Regenerative Biomaterials, Research Institute for Medical Innovation, Radboudumc, Nijmegen, The Netherlands
1 shared publication - Eppo Bonne Wolvius
Department of Oral and Maxillofacial Surgery, Special Dental Care and Orthodontics, Erasmus University Medical Center, Rotterdam, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 19 May 2025
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 53 (8) , 1205-1212
Semi-automated three-dimensional analysis of maxillary anomalies in patients with Muenke syndrome, Saethre-Chotzen syndrome or TCF12-related craniosynostosis: A retrospective study
- 19 May 2025
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 53 (8) , 1205-1212
Open AccessSemi-automated three-dimensional analysis of maxillary anomalies in patients with Muenke syndrome, Saethre-Chotzen syndrome or TCF12-related craniosynostosis: A retrospective study
- Open Access
- 8 December 2023
- Published by Elsevier in American Journal of Orthodontics and Dentofacial Orthopedics
- Vol. 165 (3) , 262-271.e3
The effect of surface roughening on the success of orthodontic mini-implants: A systematic review and meta-analysis
- 8 December 2023
- Published by Elsevier in American Journal of Orthodontics and Dentofacial Orthopedics
- Vol. 165 (3) , 262-271.e3
Open AccessThe effect of surface roughening on the success of orthodontic mini-implants: A systematic review and meta-analysis
- Open Access
- 30 April 2023
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 25 (3) , 490-501
Influence of bisphosphonate treatment on bone substitute performance in osteoporotic conditions
Objective: Considering the elevated number of osteoporotic patients in need of bone graft procedures, we here evaluated the effect of alendronate (ALN) treatment on the regeneration of bone defects in osteoporotic rats. Bone formation was histologically and histomorphometrically assessed in rat femoral condyle bone defects filled with bone graft (Bio‐Oss®) or left empty.Methods: Male Wistar rats were induced osteoporotic through orchidectomy (ORX) and SHAM‐operated. The animals were divided into three groups: osteoporotic (ORX), osteoporotic treated with ALN (ORX + ALN) and healthy (SHAM). Six weeks after ORX or SHAM surgeries, bone defects were created bilaterally in femoral condyles; one defect was filled with Bio‐Oss® and the other one left empty. Bone regeneration within the defects was analyzed by histology and histomorphometry after 4 and 12 weeks.Results: Histological samples showed new bone surrounding Bio‐Oss® particles from week 4 onward in all three groups. At week 12, the data further showed that ALN treatment of osteoporotic animals enhanced bone formation to a 10‐fold increase compared to non‐treated osteoporotic control. Bio‐Oss® filling of the defects promoted bone formation at both implantation periods compared to empty controls.Conclusion: Our histological and histomorphometric results demonstrate that the enteral administration of alendronate under osteoporotic bone conditions leverages bone defect regeneration to a level comparable to that in healthy bone. Additionally, Bio‐Oss® is an effective bone substitute, increasing bone formation, and acting as an osteoconductive scaffold guiding bone growth in both healthy and osteoporotic bone conditions.Significance: Based on the results of this study, enteral use of ALN mitigates adverse effects of an osteoporotic condition on bone defect regeneration.
- 30 April 2023
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 25 (3) , 490-501
Open AccessInfluence of bisphosphonate treatment on bone substitute performance in osteoporotic conditions
Objective: Considering the elevated number of osteoporotic patients in need of bone graft procedures, we here evaluated the effect of alendronate (ALN) treatment on the regeneration of bone defects in osteoporotic rats. Bone formation was histologically and histomorphometrically assessed in rat femoral condyle bone defects filled with bone graft (Bio‐Oss®) or left empty.Methods: Male Wistar rats were induced osteoporotic through orchidectomy (ORX) and SHAM‐operated. The animals were divided into three groups: osteoporotic (ORX), osteoporotic treated with ALN (ORX + ALN) and healthy (SHAM). Six weeks after ORX or SHAM surgeries, bone defects were created bilaterally in femoral condyles; one defect was filled with Bio‐Oss® and the other one left empty. Bone regeneration within the defects was analyzed by histology and histomorphometry after 4 and 12 weeks.Results: Histological samples showed new bone surrounding Bio‐Oss® particles from week 4 onward in all three groups. At week 12, the data further showed that ALN treatment of osteoporotic animals enhanced bone formation to a 10‐fold increase compared to non‐treated osteoporotic control. Bio‐Oss® filling of the defects promoted bone formation at both implantation periods compared to empty controls.Conclusion: Our histological and histomorphometric results demonstrate that the enteral administration of alendronate under osteoporotic bone conditions leverages bone defect regeneration to a level comparable to that in healthy bone. Additionally, Bio‐Oss® is an effective bone substitute, increasing bone formation, and acting as an osteoconductive scaffold guiding bone growth in both healthy and osteoporotic bone conditions.Significance: Based on the results of this study, enteral use of ALN mitigates adverse effects of an osteoporotic condition on bone defect regeneration.
- Open Access
- 1 October 2021
- Published by Elsevier in Journal of the Mechanical Behavior of Biomedical Materials
- Vol. 122, 104651
Innovative implant design for continuous implant stability: A mechanical and histological experimental study in the iliac crest of goats
- 1 October 2021
- Published by Elsevier in Journal of the Mechanical Behavior of Biomedical Materials
- Vol. 122, 104651
Open AccessInnovative implant design for continuous implant stability: A mechanical and histological experimental study in the iliac crest of goats
- 18 June 2006
- Published by Springer Nature
- p. 149-181
A SPATIAL–TEMPORAL MODEL OF THE INTERACTION OF SHELLFISH AND BIRDS IN A MARINE ECOSYSTEM
- 18 June 2006
- Published by Springer Nature
- p. 149-181
A SPATIAL–TEMPORAL MODEL OF THE INTERACTION OF SHELLFISH AND BIRDS IN A MARINE ECOSYSTEM